Skip to main content
Signal8
Lambert Nicole profile photo

Nicole Lambert

CIK: 0001770252

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arcus Biosciences, Inc. logo
RCUS

Arcus Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Jun 11, 2026
    Award(A)
    Direct
    5.7K shares-
  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Jun 10, 2025
    Award(A)
    Direct
    13.3K shares-

1-2 of 2

About Lambert Nicole

Lambert Nicole (SEC CIK 0001770252) files insider reports with the SEC as Director of Arcus Biosciences, Inc. (RCUS).

Signal8 holds 2 ownership filings by Lambert Nicole, all Form 4s, filed between Jun 12, 2025 and Jun 12, 2026. Those filings report 2 transactions, from Jun 10, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lambert Nicole's filings is in HAYWARD, CA.

Recent filings by Lambert Nicole

  • Jun 11, 2026: Grant or award of RCUS shares (Form 4, code A).
  • Jun 10, 2025: Grant or award of RCUS shares (Form 4, code A).

Other insiders filing for Arcus Biosciences, Inc. (RCUS)

How to read Form 4 transaction codes